252 related articles for article (PubMed ID: 22918191)
1. Ophthalmic antihistamines and H1-H4 receptors.
Wade L; Bielory L; Rudner S
Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):510-6. PubMed ID: 22918191
[TBL] [Abstract][Full Text] [Related]
2. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
Sharif NA; Xu SX; Yanni JM
J Ocul Pharmacol Ther; 1996; 12(4):401-7. PubMed ID: 8951676
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
[TBL] [Abstract][Full Text] [Related]
4. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
5. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.
Sharif NA; Su SX; Yanni JM
J Ocul Pharmacol; 1994; 10(4):653-64. PubMed ID: 7714409
[TBL] [Abstract][Full Text] [Related]
6. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
[TBL] [Abstract][Full Text] [Related]
7. Histamine receptors and the conjunctiva.
Bielory L; Ghafoor S
Curr Opin Allergy Clin Immunol; 2005 Oct; 5(5):437-40. PubMed ID: 16131920
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
Sharif NA; Wiernas TK; Griffin BW; Davis TL
Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
[TBL] [Abstract][Full Text] [Related]
9. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
Yates SL; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Tedford CE
J Pharmacol Exp Ther; 1999 May; 289(2):1151-9. PubMed ID: 10215699
[TBL] [Abstract][Full Text] [Related]
10. The future antihistamines: histamine H3 and H4 receptor ligands.
Yu F; Bonaventure P; Thurmond RL
Adv Exp Med Biol; 2010; 709():125-40. PubMed ID: 21618893
[TBL] [Abstract][Full Text] [Related]
11. Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease.
Janeczko P; Norris MR; Bielory L
Curr Opin Allergy Clin Immunol; 2021 Oct; 21(5):480-485. PubMed ID: 34387278
[TBL] [Abstract][Full Text] [Related]
12. Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
Ben-Eli H; Solomon A
Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):411-416. PubMed ID: 30020258
[TBL] [Abstract][Full Text] [Related]
13. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
14. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J; Sánchez JC; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[TBL] [Abstract][Full Text] [Related]
15. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells.
Hofstra CL; Desai PJ; Thurmond RL; Fung-Leung WP
J Pharmacol Exp Ther; 2003 Jun; 305(3):1212-21. PubMed ID: 12626656
[TBL] [Abstract][Full Text] [Related]
16. Histamine H4 receptor antagonists: the new antihistamines?
Fung-Leung WP; Thurmond RL; Ling P; Karlsson L
Curr Opin Investig Drugs; 2004 Nov; 5(11):1174-83. PubMed ID: 15573868
[TBL] [Abstract][Full Text] [Related]
17. Histamine and migraine revisited: mechanisms and possible drug targets.
Worm J; Falkenberg K; Olesen J
J Headache Pain; 2019 Mar; 20(1):30. PubMed ID: 30909864
[TBL] [Abstract][Full Text] [Related]
18. Antihistamines in rhinoconjunctivitis.
Howarth P
Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
[TBL] [Abstract][Full Text] [Related]
19. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
[TBL] [Abstract][Full Text] [Related]
20. [Molecular imaging of histamine receptors in the human brain].
Tashiro M; Yanai K
Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
